Roche Sees Glass Half Full After Ipatasertib Data

Hit One Co-Primary Endpoint, Missed The Other

Glass_Of_Water
Roche accentuates the positive in ipatasertib study • Source: Shutterstock

More from Anticancer

More from Therapeutic Category